1 results match your criteria: "Lifecare Institute of Medical Sciences and Research[Affiliation]"
First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial.
EuroIntervention
August 2013
Lifecare Institute of Medical Sciences and Research, Ahmedabad, Gujarat, India.
Article Synopsis
- The BioMimeTM sirolimus-eluting stent (SES) is a new medical device designed for treating coronary lesions, evaluated in the meriT-1 trial.
- The trial involved 30 patients with various risk factors and showed a 100% procedural success rate, with no cases of significant restenosis or major adverse cardiovascular events (MACE) observed after 12 months.
- Results indicated low late lumen loss at eight months, suggesting effective performance and safety of the BioMime SES for patients with coronary artery issues.